APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Abroad (travel likely)RecruitingPHASE3

Conditions

Pre-Eclampsia · Pregnancy Loss

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Theresa Delahanty) · theresa.delahanty@pennmedicine.upenn.edu
Contact: Study coordinator (Andrea Morley) · andrea.morley@pennmedicine.upenn.edu

Study leads

Enrique Schisterman, PhD
Principal Investigator
University of Pennsylvania
Kurt Barnhart, MD
Principal Investigator
University of Pennsylvania

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology

ART · Pre-Eclampsia

Abroad (travel likely)RecruitingPHASE3

Angers, France · Bordeaux, France

Screening for Preeclampsia in Norway With Aspirin Discontinuation at 24-28 Weeks

Pre-Eclampsia

Abroad (travel likely)Recruiting

Trondheim, Norway

Treatment With Aspirin After Preeclampsia: TAP Trial

Hypertensive Disorder of Pregnancy · Pre-Eclampsia · Hypertension

Abroad (travel likely)RecruitingPHASE4

Pittsburgh, United States

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia

Hypertension · Pre-eclampsia

Abroad (travel likely)Recruiting

Yerevan, Armenia